Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

Graphite Bio (GRPH)

Graphite Bio Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:GRPH
DateTimeSourceHeadlineSymbolCompany
08/03/202422:17Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
08/03/202422:13Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
08/03/202422:00Business WireGraphite Bio Declares Special Dividend In Connection with Proposed Merger with Lenz TherapeuticsNASDAQ:GRPHGraphite Bio Inc
05/03/202411:09Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
05/03/202411:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
27/02/202421:11Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:GRPHGraphite Bio Inc
13/02/202421:44Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:GRPHGraphite Bio Inc
09/02/202422:23Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:GRPHGraphite Bio Inc
05/02/202421:57Edgar (US Regulatory)Form S-4/A - Registration of securities, business combinations: [Amend]NASDAQ:GRPHGraphite Bio Inc
05/02/202421:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GRPHGraphite Bio Inc
26/12/202321:37Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
26/12/202321:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
06/12/202321:57Edgar (US Regulatory)Form S-4 - Registration of securities, business combinationsNASDAQ:GRPHGraphite Bio Inc
15/11/202322:23Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
15/11/202313:09Edgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:GRPHGraphite Bio Inc
15/11/202313:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
15/11/202312:00Business WireLENZ Therapeutics and Graphite Bio Announce Merger AgreementNASDAQ:GRPHGraphite Bio Inc
30/10/202320:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
13/09/202321:06Edgar (US Regulatory)Form 8-K/A - Current report: [Amend]NASDAQ:GRPHGraphite Bio Inc
23/08/202321:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
14/08/202322:04Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GRPHGraphite Bio Inc
02/08/202321:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
21/07/202322:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
21/07/202322:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
21/07/202322:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
21/07/202322:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GRPHGraphite Bio Inc
20/07/202313:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GRPHGraphite Bio Inc
23/06/202312:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GRPHGraphite Bio Inc
23/06/202312:00Business WireGraphite Bio Announces Departure of Chief Financial OfficerNASDAQ:GRPHGraphite Bio Inc
06/06/202321:16Edgar (US Regulatory)Annual Report to Security Holders (ars)NASDAQ:GRPHGraphite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:GRPH